Table 2.

Identity and immunopotency of clinical bacthes of MSC,WJ

PBMC	MSC batch	CD45−/CD105+ (%)	CD31−CD73+ (%)	HLADR−/CD90+ (%)	CD90+ (%)	Inhibition of proliferation
Individual donors (fresh)	1	99.9	99.8	99.4	99.9	62%
	2	99.9	99.9	99.3	99.7	97%
	3	99.9	99.9	99.5	99.8	84%
	4	100	99.9	99.5	99.7	103%
	5	99.7	99.4	99.2	99.7	64%
	6	99.9	99.7	99.5	99.9	69%
	7	100	99.9	998	99.9	86%
	8	99.7	99.8	99.8	99.9	57%
	9	99.7	99.9	99.8	99.9	55%
Pooled from 5 donors (cryopreserved)	10	99.8	99.9	99.9	100	86%
	11	99.5	99.8	99.6	99.8	81%
	12	99.1	99.8	99.9	100	70%
	13	100	99.8	99.8	100	59%
	14	100	99.5	99.6	100	61%
	15	99.8	99.6	99.9	100	58%
	16	99.4	99.7	99.6	100	73%
	17	98.7	99.8	99.6	99.8	57%
	18	98.7	99.6	99.6	100	63%
	19	97.6	99.7	99.2	99.9	60%
	20	99.8	99.6	99.4	100	65%